NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (AMEX:NBS), the first company to specialize in the collection, processing and storage of stem cells from healthy adults for personal use in times of critical medical need, has cited a growing number of publications and body of data from clinical trials that further support the Company’s business strategy.
